Disc Medicine, Inc.
IRON
$92.38
$2.662.97%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -134.30% | -109.65% | -26.48% | -24.93% | -88.35% |
| Total Depreciation and Amortization | 690.91% | -22.73% | -23.08% | -64.00% | -56.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 344.41% | 90.87% | -0.71% | 341.90% | 38.60% |
| Change in Net Operating Assets | -14.51% | -96.07% | -5.56% | -109.54% | 39.55% |
| Cash from Operations | -175.32% | -211.30% | -23.15% | -54.94% | -132.22% |
| Capital Expenditure | -425.00% | -1,300.00% | -1,170.15% | -14,866.67% | 117.78% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 169.71% | 123.54% | -- | -- | -- |
| Cash from Investing | 169.68% | 123.52% | -406,814.93% | -47,433.33% | -157,877.78% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2,620.19% | -99.48% | 1,377.14% | -84.51% | -17.76% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2,620.19% | -99.48% | 1,436.17% | 271.19% | -7.39% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 115.14% | 107.53% | -292.65% | 97.99% | -1,146.64% |